Neuer

DGAP-News: Notification of performed Stabilisation Measures pursuant to Article 5 (4) (b) and (5) of Reg. (EU) No 596/2014 (MAR); Article 6 (2) of the Com. Delegated Reg. (EU) 2016/1052

Retrieved on: 
Monday, November 29, 2021

Notification of performed Stabilisation Measures pursuant to Article 5 (4) (b) and (5) of Reg.

Key Points: 
  • Notification of performed Stabilisation Measures pursuant to Article 5 (4) (b) and (5) of Reg.
  • (EU) No 596/2014 (MAR); Article 6 (2) of the Com.
  • Delegated Reg.
  • (EU) 2016/1052 (news with additional features)
    The issuer is solely responsible for the content of this announcement.

DGAP-News: Notification of performed Stabilisation Measures pursuant to Article 5 (4) (b) and (5) of Reg. (EU) No 596/2014 (MAR); Article 6 (2) of the Com. Delegated Reg. (EU) 2016/1052

Retrieved on: 
Monday, November 22, 2021

Notification of performed Stabilisation Measures pursuant to Article 5 (4) (b) and (5) of Reg.

Key Points: 
  • Notification of performed Stabilisation Measures pursuant to Article 5 (4) (b) and (5) of Reg.
  • (EU) No 596/2014 (MAR); Article 6 (2) of the Com.
  • Delegated Reg.
  • (EU) 2016/1052 (news with additional features)
    The issuer is solely responsible for the content of this announcement.

DGAP-News: Notification of performed Stabilisation Measures pursuant to Article 5 (4) (b) and (5) of Reg. (EU) No 596/2014 (MAR); Article 6 (2) of the Com. Delegated Reg. (EU) 2016/1052

Retrieved on: 
Monday, November 15, 2021

Notification of performed Stabilisation Measures pursuant to Article 5 (4) (b) and (5) of Reg.

Key Points: 
  • Notification of performed Stabilisation Measures pursuant to Article 5 (4) (b) and (5) of Reg.
  • (EU) No 596/2014 (MAR); Article 6 (2) of the Com.
  • Delegated Reg.
  • (EU) 2016/1052 (news with additional features)
    The issuer is solely responsible for the content of this announcement.

Dr. Stephan Wnendt and Dr. Katja Neuer Join Achelous Partners as European Representatives

Retrieved on: 
Tuesday, January 5, 2021

NEW YORK, Jan. 5, 2021 /PRNewswire-PRWeb/ --Achelous Partners, LLC is pleased to announce that Dr. Stephan Wnendt and Dr. Katja Neuer have been appointed as European Representatives.

Key Points: 
  • NEW YORK, Jan. 5, 2021 /PRNewswire-PRWeb/ --Achelous Partners, LLC is pleased to announce that Dr. Stephan Wnendt and Dr. Katja Neuer have been appointed as European Representatives.
  • Dr. Wnendt and Dr. Neuer are both based in Germany, which is one of Achelous Partners' fastest growing markets in Europe.
  • Dr. Wnendt and Dr. Neuer will significantly bolster our ability to assist our clients in Germany, as well as locate new opportunities globally," said Mark Saunders, President of Achelous Partners.
  • Dr. Wnendt and Dr. Neuer join Achelous Partners from MLM Medical Labs GmbH, where Dr. Wnendt served as CEO and Dr. Neuer served as Director of Business Development.